DRI Capital Inc.
PE/Buy-Out · Toronto (Canada)
Sign up free to access full profile and submit your pitch.
About
DRI Capital Inc. is a private equity firm specializing in investments in late venture and buyouts. It seeks to invest in medically necessary therapeutics, market leading products, strong intellectual property protection and leading marketers, products in healthcare and life sciences sector that treat chronic, and or rare diseases which improve the health and quality of a patient’s life. The firm seeks to acquire royalties globally from pharmaceutical and biotechnology companies, research institutes, universities, and inventors. Additionally, it considers investments in royalty entitlements on medical devices, diagnostic products, life sciences tools and technologies, drug, and pharmaceutical products. The firm invests worldwide with a focus on Japan, Europe, and the United States. It invests in synthetic royalties, debt, and structured debt/equity instruments of both public and private companies. DRI Capital Inc., formerly known as Drug Royalty Corporation Inc., was founded in 1992 and is based in Toronto, Canada with additional offices in New York, New York and Short Hills, New Jersey.
Visit website ↗Investment Criteria
Sign up free to see full investment criteria and submit your pitch.
.png)
